Home
/
TransMedics Group, Inc.
/
Financials
/
Quarterly
TransMedics Group, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TransMedics Group, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$143.82M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$157.37M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$143.54M
May 8, 2025
Q3
2025
Sep 30, 2024
$108.76M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$114.31M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$96.85M
May 8, 2025
Q3
2024
Sep 30, 2023
$66.43M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$52.47M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$41.55M
May 2, 2024
Q3
2023
Sep 30, 2022
$25.68M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$20.52M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$15.88M
May 4, 2023
Q3
2022
Sep 30, 2021
$5.37M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$8.17M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$7.05M
May 5, 2022
Q3
2021
Sep 30, 2020
$7.09M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$3.39M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$7.53M
May 7, 2021
Q3
2020
Sep 28, 2019
$7.21M
Nov 6, 2020
Q2
2020
Jun 29, 2019
$5.67M
Aug 7, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$24.30M
Nov 4, 2022
Q2
2022
Jun 30, 2022
$20.52M
Aug 3, 2022
Q1
2022
Mar 31, 2022
$15.88M
May 5, 2022
Q3
2022
Sep 30, 2021
$5.41M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$8.67M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$7.64M
May 5, 2022
Q3
2021
Sep 30, 2020
$7.97M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$3.92M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$8.24M
May 7, 2021
Q3
2020
Sep 28, 2019
$7.88M
Nov 6, 2020
Q2
2020
Jun 29, 2019
$6.22M
Aug 7, 2020
Q1
2020
Mar 30, 2019
$5.29M
May 6, 2020
Q3
2019
Sep 29, 2018
$4.76M
Nov 8, 2019
Q2
2019
Jun 30, 2018
$3.26M
Aug 8, 2019
Q1
2019
Mar 31, 2018
$2.76M
Jun 12, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$24.32M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$34.91M
Jul 30, 2025
Q3
2025
Jun 30, 2025
$34.91M
Oct 29, 2025
Q2
2025
Mar 31, 2025
$25.68M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$25.68M
May 8, 2025
Q3
2025
Mar 31, 2025
$25.68M
Oct 29, 2025
Q3
2025
Sep 30, 2024
$4.22M
Oct 29, 2025
Q3
2025
Jun 30, 2024
$12.19M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$12.19M
Jul 30, 2025
Q3
2025
Mar 31, 2024
$12.20M
Oct 29, 2025
Q1
2025
Mar 31, 2024
$12.20M
May 8, 2025
Q2
2025
Mar 31, 2024
$12.20M
Jul 30, 2025
Q3
2024
Sep 30, 2023
($25.42M)
Oct 29, 2024
Q3
2024
Jun 30, 2023
($1.00M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($1.00M)
Aug 1, 2024
Q3
2024
Mar 31, 2023
($2.64M)
Oct 29, 2024
Q1
2024
Mar 31, 2023
($2.64M)
May 2, 2024
Q2
2024
Mar 31, 2023
($2.64M)
Aug 1, 2024
Q2
2023
Dec 31, 2022
($36.20M)
Aug 4, 2023
Q1
2023
Dec 31, 2022
($36.20M)
May 4, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$23.30M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$36.57M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$27.44M
May 8, 2025
Q3
2025
Sep 30, 2024
$3.92M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$12.51M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$12.42M
May 8, 2025
Q3
2024
Sep 30, 2023
($28.34M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($906.0K)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($2.09M)
May 2, 2024
Q3
2023
Sep 30, 2022
($5.54M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($9.75M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($9.37M)
May 4, 2023
Q3
2022
Sep 30, 2021
($11.73M)
Nov 4, 2022
Q2
2022
Jun 30, 2021
($9.87M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($6.51M)
May 5, 2022
Q3
2021
Sep 30, 2020
($4.61M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($7.86M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($8.02M)
May 7, 2021
Q3
2020
Sep 28, 2019
($7.24M)
Nov 6, 2020
Q2
2020
Jun 29, 2019
($7.71M)
Aug 7, 2020